A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, ...
US-based healthcare system Tanner Health is deploying the Abridge AI platform for clinical conversations across its network.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback